SCHEMBL26885205

SCHEMBL26885205

O=C(Nc1ccccc1)c1ccc(-c2ccc(NC(=O)c3ccc4ccccc4c3)cc2)nc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 1/20 0.66
▸ PTPN1 P18031 2/20 0.64
▸ PTPN2 P17706 1/20 0.64
▸ DEGS1 O15121 1/20 0.59
▸ NPC1 O15118 3/20 0.58
▸ RAB9A P51151 3/20 0.58
▸ KDM4E B2RXH2 2/20 0.58
▸ NR1H4 Q96RI1 1/20 0.56
▸ GPR27 Q9NS67 1/20 0.56
▸ PLAU P00749 4/20 0.56
▸ CASP3 P42574 1/20 0.55
▸ SENP7 Q9BQF6 1/20 0.55
▸ PTPN6 P29350 1/20 0.55
▸ PTPN11 Q06124 1/20 0.55
▸ DGAT1 O75907 2/20 0.55
▸ ALDH1A1 P00352 1/20 0.55
▸ PTGDR2 Q9Y5Y4 1/20 0.54
▸ MEN1 O00255 1/20 0.54
▸ KMT2A Q03164 1/20 0.54
▸ F2 P00734 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26885211 0.95 TRPV1 (0.66) TRPV1PTPN1PTPN2DEGS1NPC1
SCHEMBL26885207 0.94 PTPN1 (0.74) TRPV1PTPN1PTPN2DEGS1NPC1
SCHEMBL26891626 0.94 PTPN1 (0.62) TRPV1PTPN1PTPN2DEGS1NPC1
SCHEMBL26885195 0.94 TRPV1 (0.68) TRPV1PTPN1PTPN2DEGS1NPC1
SCHEMBL26885196 0.94 TRPV1 (0.68) TRPV1PTPN1PTPN2DEGS1NPC1
SCHEMBL26885219 0.92 PTPN1 (0.71) TRPV1PTPN1PTPN2DEGS1NPC1
SCHEMBL26885216 0.91 PTPN1 (0.78) TRPV1PTPN1PTPN2DEGS1NPC1
SCHEMBL26885271 0.91 PTPN1 (0.78) TRPV1PTPN1PTPN2DEGS1NPC1
SCHEMBL26885203 0.91 DEGS1 (0.60) TRPV1PTPN1PTPN2DEGS1NPC1
SCHEMBL26885199 0.90 TRPV1 (0.69) TRPV1PTPN1PTPN2DEGS1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381159-A1 SMALL MOLECULE INHIBITORS OF CORONAVIRUS ATTACHMENT AND ENTRY, METHODS AND USES THEREOF UNIVERSITY OF MIAMI 2023-11-30 — — US disclosed
US-20230381159-A1 SMALL MOLECULE INHIBITORS OF CORONAVIRUS ATTACHMENT AND ENTRY, METHODS AND USES THEREOF UNIVERSITY OF MIAMI 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381159-A1 SMALL MOLECULE INHIBITORS OF CORONAVIRUS ATTACHMENT AND ENTRY, METHODS AND USES THEREOF ACE2, ACE, SARS1 TRPV1 1641/4885PTPN1 3453/4885PTPN2 3483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback